Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin in T2DM with LV Dysfunction (DYDA2)
NCT02851745Phase 3Completed
- Sponsor
- Heart Care Foundation of India
- Start
- Jul 2015
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linagliptin in left ventricular systolic dysfunction (LVSD), sponsored by Heart Care Foundation of India. Started Jul 2015; status: completed.
02
Drugs
linagliptin
03
Conditions
left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on NCT02851745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02851745.